In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

First-ever trial over Zantac cancer claims gets underway in Cook County The lawsuit is one of many claims made nationwide that the over-the-counter heartburn drug Zantac and its generics have an ...

The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed by five months.

Although most drugmakers had already pulled the heartburn products months ago, the agency told consumers they should throw out any over-the-counter medications they still had.

CVS Pharmacy announced it's pulling the heartburn medication Zantac from its shelves over a possible link to cancer. The popular over-the-counter drug and CVS' own generic brand — ranitidine ...

"CVS Pharmacy has suspended the sale of all Zantac brand and CVS Health brand ranitidine products until further notice," a spokesperson for the brand wrote in a press release.

The pharmacy chains are pulling the heartburn medication from shelves after the Food and Drug Administration warned that it had detected low levels of a cancer-causing chemical in samples of the drug.

A division of Novartis, a pharmaceutical company based in Switzerland, has halted shipments of generic versions of the heartburn medication Zantac after the Food and Drug Administration (FDA ...